Results 31 to 40 of about 298,421 (156)
Vesico-bullous subacute cutaneous lupus erythematosus – An uncommon entity successfully treated with dapsone and hydroxychloroquine [PDF]
Vesico-bullous subacute cutaneous lupus erythematosus is an uncommon and severe presentation. The authors report an exuberant case of vesico-bullous subacute cutaneous lupus erythematosus successfully treated with dapsone and ...
Sanches, Madalena +12 more
core +1 more source
Congenital lupus erythematosus
Neonatal lupus erythematosus (NLE) is an autoimmune disease affecting the fetus as a result of transplacental transfer of anti-Ro autoantibodies. Typically, it presents in the first few months of life with an annular form of subacute cutaneous lupus ...
Taseer Ahmed Bhatt +2 more
doaj +1 more source
Os autores relatam caso de lúpus eritematoso cutâneo subagudo (LECSA) manifestado clinicamente como eritema anular centrífugo. Ressaltam a diferenciação clínica e laboratorial entre LECSA e lúpus eritematoso sistêmico.
Ney Romiti +4 more
doaj +1 more source
Subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus are represented in the majority of cutaneous lupus subtypes, each of which has variable implications for systemic manifestations such as lupus nephritis.
McLean-Mandell, Riley E +7 more
core +1 more source
Bullous subacute cutaneous lupus erythematosus
We describe a 59-year-old woman, with a history of autoimmune disease and disseminated uterine leiomyosarcoma, who developed a photoaggravated, blistering skin eruption.
McGibbon, D H, Black, M M, Perera, G K
core +1 more source
Capecitabine is a fluoropyrimidine chemotherapy prodrug of 5-fluorouracil (5-FU) used in the treatment of metastatic breast and colorectal cancers.
Darwin, Evan +5 more
core +1 more source
Most patients with systemic lupus erythematosus (SLE) present with some form of skin involvement. Skin manifestations of lupus are classified as lupus-specific or lupus-nonspecific based on histopathologic findings.
S. K. Solovyev, E. A. Aseeva
doaj +1 more source
Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato +5 more
wiley +1 more source
Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature [PDF]
Cutaneous manifestations occur frequently in systemic lupus erythematosus (SLE) and are pathognomonic in subacute-cutaneous lupus erythematosus (SCLE) and chronic cutaneous lupus erythematosus (CCLE).
Morris, SD +3 more
core
Neonatal lupus erythematosus presenting as Stevens-Johnson syndrome
Neonatal lupus erythematosus (NLE) is a rare acquired condition caused by the transplacental passage of maternal autoantibodies. It is characterized by cutaneous, cardiac, hepatobiliary, hematological and neurological involvement.
Ren-Feng Liu +4 more
doaj +1 more source

